Sign in

Krones AG KRN.DE

Price 116.0 EUR
as of 2026-09-05
61/100
Mixed
Quality55
Growth45
Balance-sheet strength80
Valuation75
Momentum38
Income68

Composite 61/100; the shares have moved about 26% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Momentum ranks 38/100 — a moderate mark against it.

Case for

Balance-sheet strength ranks 80/100 — a strong point in its favour. Valuation ranks 75/100 — a moderate point in its favour. Income ranks 68/100 — a moderate point in its favour.

Case against

Momentum ranks 38/100 — a moderate mark against it. Growth ranks 45/100 — a slight mark against it.

What the company does Krones AG designs, builds, and installs process, filling, and packaging lines for beverages and liquid foods across PET bottling, recycling, process technology (beer, juices, dairy, alternative proteins), and intralogistics automation. It also supplies water treatment, pumps, and digitalization solutions.

Key financials Krones posts gross margins of 52.8%, operating margins of 4.2%, and net margins of 5.1%. ROE is 13.9%, ROA 4.7%, and ROCE 15.7%. Revenue fell 2.5% and EPS 9.6% in the latest period, with a debt/equity of 0.02 and current ratio of 1.42.

Stock health Sideravia scores Krones “Average quality, attractively valued, weak momentum” with an overall 54.9/100. Quality 52.0, Growth 22.2, Strength 74.3, Valuation 74.2, Momentum 34.2, Income 74.8. RSI(14) is 65.20.

Price vs fair value Krones trades at a PREMIUM of 28.60% versus our fair-value estimate of 83.97 and at a discount of 30.57% versus the 12-month target of 153.56. - Q2 earnings call highlighted softer order intake and margin pressure (MarketBeat) - Forward P/E of 21.01 vs trailing P/E of 12.36 signals high expectations - Valuation percentile 74.2/100 ranks in the top quartile on valuation metrics

Looking forward Analysts (nine) expect a 12-month price of 153.56, implying 30.57% upside from today’s 117.60, contingent on demand recovery and margin stabilization.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.